Molecular Formula: C₁₆H₁₉N₃O₅ Molecular Weight: 333.34 g/mol Sequence: Glu-Trp (EW) Purity: >99% Vial Size: 20mg Storage: -20°C, protect from light

Product Overview

Thymagen represents advanced bioregulatory peptide technology designed for comprehensive immune system, anti-aging, and regenerative medicine research applications. This Khavinson-developed dipeptide demonstrates unique ability to modulate immune cell function through direct interaction with T-lymphocyte development pathways and cyclic nucleotide regulation. Originally isolated from calf thymus and now synthesized via recombinant DNA techniques, Thymagen offers researchers unprecedented opportunities to investigate immune regulation, cellular regeneration, and longevity mechanisms.

Revolutionary Immune Mechanism

Thymagen functions as a specialized thymic bioregulator, directly influencing T-lymphocyte precursor maturation into immunocompetent T-cells through cyclic nucleotide pathway modulation. The peptide down-regulates cyclic nucleotide catabolism, effectively increasing intracellular cAMP and cGMP levels to enhance immune cell responsiveness. This mechanism promotes interferon secretion, stimulates natural killer cell activity, and optimizes immune surveillance capabilities while preventing autoimmune reactions.

Primary Research Applications

Cancer Prevention Research Comprehensive studies demonstrate Thymagen's ability to reduce tumor incidence by 50% while decreasing malignant tumor development by 70% in experimental models. Research shows enhanced immune surveillance against radiation-induced carcinogenesis with extended survival rates. Applications include investigating natural killer cell mechanisms, immune system cancer surveillance, and tumor suppression pathways.

Cardiovascular Protection Studies Clinical research reveals significant cardioprotective effects through anti-arrhythmic properties and ischemia-reperfusion injury prevention. Studies demonstrate superior protective capabilities compared to conventional drugs like verapamil in isolated heart models. Research applications encompass cardiac ischemia protection, arrhythmia prevention, and myocardial injury recovery mechanisms.

Immune System Enhancement Research demonstrates Thymagen's capacity to normalize lymphocyte counts, increase T-cell functional activity, and stimulate cellular immunity responses. Studies show enhanced resistance to bacterial infections, improved humoral antibody responses, and reduced inflammatory cytokine levels. Applications include immunodeficiency research, infection resistance studies, and immune aging investigations.

Diabetes Complications Research Clinical studies reveal 95% efficacy in correcting secondary immunodeficiency associated with type 1 diabetes. Research demonstrates improved candidiasis resistance and enhanced immune function in diabetic models. Applications encompass diabetic immunocompromise studies, fungal infection resistance research, and metabolic-immune interactions.

Surgical Recovery Research Studies demonstrate reduced post-operative complications, accelerated healing rates, and decreased infection risks when administered pre-operatively. Research shows shortened recovery periods and enhanced immune function during vulnerable perioperative phases, particularly in elderly populations.

Mechanism of Action

Cyclic Nucleotide Regulation: Enhanced cAMP/cGMP levels improving cellular signaling pathways T-Cell Maturation: Direct promotion of lymphocyte precursor differentiation into functional immune cells Interferon Stimulation: Increased production of antiviral and immune regulatory signaling proteins Inflammatory Modulation: Normalized lymphocyte counts with reduced pro-inflammatory cytokines Natural Killer Enhancement: Boosted innate immune surveillance against pathogens and malignancies Anti-Aging Effects: Cellular regeneration promotion and senescence prevention mechanisms

Research Advantages

Dual-Target Action: Simultaneously enhances immune function while providing tissue protection Clinical Validation: Extensive human studies confirming safety and efficacy profiles Multi-System Benefits: Immune, cardiovascular, metabolic, and regenerative applications No Side Effects: Well-tolerated bioregulatory approach with minimal adverse reactions Geroprotective Properties: Demonstrated life extension and healthy aging capabilities Tissue-Specific Accumulation: Concentrates in liver, thymus, lymph nodes for targeted effects Anti-Infection Properties: Enhanced resistance to viral, bacterial, and fungal pathogens

Quality Specifications

Every Thymagen batch undergoes comprehensive quality control:

• HPLC-MS purity analysis confirming >99% purity

• Amino acid sequence verification (Glu-Trp)

• Molecular weight confirmation at 333.34 g/mol

• CAS number validation (38101-59-6)

• Endotoxin testing (<0.1 EU/mg)

• Bioactivity assays using immune cell lines

• Certificate of Analysis provided with shipment

Storage & Reconstitution

Store lyophilized powder at -20°C in sealed vials. Protect from light and humidity. Reconstitute with bacteriostatic water immediately before use. Once reconstituted, use within 24 hours or store at -80°C for short-term applications. Avoid repeated freeze-thaw cycles to maintain immune-modulating potency and biological activity.

Research Protocol Applications

• Immune system enhancement and T-cell development studies

• Cancer prevention and tumor suppression mechanism research

• Cardiovascular protection and anti-arrhythmic investigations

• Diabetes complications and immunocompromise studies

• Surgical recovery and wound healing research

• Anti-aging and longevity mechanism investigations

• Infection resistance and antimicrobial immunity studies

• Inflammatory modulation and autoimmune research

Clinical Translation Potential

Thymagen research benefits from four decades of investigation by Professor Vladimir Khavinson with extensive validation in clinical applications. The peptide's proven mechanisms in immune enhancement, cancer prevention, and cardiovascular protection provide robust foundation for investigating novel therapeutic applications in immunodeficiency disorders, age-related diseases, and regenerative medicine interventions.

Research Use Only: Not for human or veterinary therapeutic applications. Handle according to laboratory safety protocols and institutional research guidelines.

Thymagen 20mg

• Typical research protocols: 5-10μg daily for immune enhancement studies

• Reconstitute with sterile bacteriostatic water

• Administration methods: Subcutaneous injection or cell culture applications

• Monitor for immune response markers and T-cell differentiation

• Regular cytokine and lymphocyte monitoring during extended protocols

• Follow institutional guidelines for immunomodulatory peptide research procedures